US OptionsDetailed Quotes
NMRA250117C1000
- 0.00
- 0.000.00%
15min DelayClose Jan 6 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest1.00Strike Price0.00Turnover0.00%IV-59.68%PremiumJan 17, 2025Expiry Date1.48Intrinsic Value100Multiplier11DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.51Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Neumora Therapeutics Stock Discussion
The average price target for Neumora Therapeutics, Inc. is $24.17. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $30.00 ,the lowest forecast is $15.00.
H.C. Wainwright reaffirmed its Buy rating and a price target of $30.00 for Neumora Therapeutics (NASDAQ:NMRA) stock.
——-
On Friday, Mizuho (NYSE:MFG) Securities reiterated its Outperform rating on Neumora Therapeutics (NASDAQ:NMRA) with a steady price target of $20.00, despite the company's recent setback with its lead drug candidate, navacaprant.
———-
jp morgan target price 15
Many antidepressants have had at least one Phase 3 failure before winning approval
No comment yet